Roche

Turning Point touts positive pivotal NSCLC data, hints at even faster OK — but can it beat Pfizer and Roche?
Endpoints
Wed, 08/19/20 - 12:18 pm
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
clinical trials
Pfizer
Roche
Regeneron, Roche team up in global deal on Covid-19 antibody cocktail
MedCity News
Wed, 08/19/20 - 11:13 am
Roche
Regeneron
COVID-19
antibodies
antibody cocktail
FDA to decide on TG Therapeutics’ lymphoma drug early next year
Pharmaforum
Thu, 08/13/20 - 11:53 pm
TG Therapeutics
FDA
lymphoma
umbralisib
Bristol-Myers Squibb
Roche
Roche pulls a tumor micro-environment drug out of the freezer, hands it to a UK upstart
Endpoints
Wed, 08/12/20 - 10:35 am
Roche
Celleron Therapeutics
solid tumors
Eisai is creating a new US corporate, R&D HQ in Roche’s old Nutley, NJ campus
Endpoints
Tue, 08/11/20 - 12:31 pm
Eisai
Roche
R&D
New Jersey
Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
Fierce Biotech
Mon, 08/10/20 - 10:53 am
Roche
Genentech
etrolizumab
clinical trials
ulcerative colitis
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
Xconomy
Sat, 08/8/20 - 10:56 pm
Roche
risdiplam
SMA
spinal muscular atrophy
FDA
In surprising setback, combo of Roche’s Tecentriq and chemo fails to help patients with triple-negative breast cancer
Endpoints
Fri, 08/7/20 - 10:56 am
Roche
FDA
triple negative breast cancer
Tecentriq
Dicerna guides Roche-partnered hepatitis B drug past early test
Fierce Biotech
Thu, 08/6/20 - 10:15 am
Roche
Dicerna Pharmaceuticals
hepatitis B
RG6346
clinical trials
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Pharmaceutical Business Review
Mon, 08/3/20 - 10:33 am
Roche
FDA
Tecentriq
Cotellic
Zelboraf
melanoma
Roche’s Tecentriq claims melanoma OK, but don’t expect a sales surge
Pharmaforum
Fri, 07/31/20 - 10:43 am
Roche
Tecentriq
FDA
melanoma
Bristol-Myers Squibb
Merck
Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia
Pharmaceutical Business Review
Thu, 07/30/20 - 10:59 am
Roche
Actemra
RoActemra
COVID-19
clinical trials
COVID-19 pneumonia
Roche doubles down on Tau
EP Vantage
Wed, 07/29/20 - 12:20 pm
Roche
anti-tau antibodies
UCB Pharma
UCB01017
Alzheimer's disease
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
FDA
drug approvals
Novartis
inclisiran
Biomarin
valrox
Roche
risdiplam
GSK
belantamab mafodotin
Gilead Sciences
Galapagos
filgotinib
Roche drops hep B antiviral as late-stage pipeline tests 'largely on track' despite COVID-19 disruption
Fierce Biotech
Thu, 07/23/20 - 11:12 am
Roche
antiviral
hepatitis B
RG6217
Roche, Jnana sign multi-target collaboration deal for small molecule drugs
Pharmaceutical Business Review
Thu, 07/23/20 - 10:58 am
Roche
Jnana Therapeutics
small molecule drugs
Roche suffers double whammy as biosimilars, COVID-19 joined hands in weak quarter
Fierce Pharma
Thu, 07/23/20 - 10:54 am
Roche
earnings
10 drugmakers expected to make the most money in the next 5 years
Beckers Hospital Review
Wed, 07/22/20 - 12:07 am
Roche
pharma industry
drug sales
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
R&D
drug development
Eli Lilly
Novartis
Argenx
Bristol-Myers Squibb
Vir Biotechnolgy
Biogen
GSK
Iovance
Roche
Roche, PicnicHealth start RWD partnership with multiple sclerosis focus
MedCity News
Mon, 07/20/20 - 10:32 am
Roche
PicnicHealth
MS
multiple sclerosis
RWD
real world data
artificial intelligence

Pages